STOCK TITAN

Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ekso Bionics, a leader in exoskeleton technology, announced participation in the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022. The management will engage in a fireside chat available on-demand starting January 10 at 4:00 AM PT. This chat will be accessible throughout the conference on the company's investor website. Founded in 2005, Ekso Bionics aims to enhance strength and mobility through innovative wearable robots. The company is publicly traded on Nasdaq under the symbol EKSO.

Positive
  • None.
Negative
  • None.

RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022.

The fireside chat will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Monday, January 10, 2022 throughout the entirety of the conference and on the investor section of the Company’s website at www.eksobionics.com.

About Ekso Bionics® 
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com


FAQ

When is the H.C. Wainwright BioConnect Virtual Conference for Ekso Bionics?

The conference will take place from January 10-13, 2022.

What is the schedule for the fireside chat featuring Ekso Bionics management?

The fireside chat will be available on-demand starting January 10, 2022, at 4:00 AM PT.

Where can I watch the Ekso Bionics fireside chat?

You can view the fireside chat on the investor section of the Ekso Bionics website.

What is the stock symbol for Ekso Bionics?

Ekso Bionics is listed on Nasdaq under the symbol EKSO.

What does Ekso Bionics develop?

Ekso Bionics develops exoskeleton solutions that enhance human strength, endurance, and mobility for medical and industrial applications.

Ekso Bionics Holdings, Inc.

NASDAQ:EKSO

EKSO Rankings

EKSO Latest News

EKSO Stock Data

13.42M
20.03M
7.91%
25.25%
0.39%
Medical Instruments & Supplies
General Industrial Machinery & Equipment, Nec
Link
United States of America
SAN RAFAEL